Triptolide-mediated inhibition of interferon signaling enhances vesicular stomatitis virus-based oncolysis. - Wikidata - awgldk - TriplyDB

Triptolide-mediated inhibition of interferon signaling enhances vesicular stomatitis virus-based oncolysis.

Triptolide-mediated inhibition of interferon signaling enhances vesicular stomatitis virus-based oncolysis.

http://www.wikidata.org/entity/Q37316872

about

Changes in Susceptibility to Oncolytic Vesicular Stomatitis Virus during Progression of Prostate Cancer.Interferon Beta and Interferon Alpha 2a Differentially Protect Head and Neck Cancer Cells from Vesicular Stomatitis Virus-Induced Oncolysis.Murine Tumor Models for Oncolytic Rhabdo-Virotherapy.Oncolytic viruses and their application to cancer immunotherapy Pharmacological modulation of anti-tumor immunity induced by oncolytic viruses.Interferon-Mediated Tumor Resistance to Oncolytic Virotherapy.Activation of Nrf2 Signaling Augments Vesicular Stomatitis Virus Oncolysis via Autophagy-Driven Suppression of Antiviral Immunity.Recent advances in vesicular stomatitis virus-based oncolytic virotherapy: a 5-year update.Tumor Restrictions to Oncolytic Virus.

P2860

Q35641491-BC12FD1A-3013-4131-8C5C-09FEBD7EDAF8 Q35861186-CFB53125-7BEE-4620-92E4-F07AAE4F962E Q36751597-71B90081-49CC-4BB2-BF4E-008FB796AC23 Q38207011-6980C9C4-915C-4089-A088-2C13E747EDE8 Q38237657-DD2BDB8D-6E5D-479D-B98B-895FED1DDB3C Q39109430-5F901CF7-6904-47CC-9772-A32AE09831B4 Q40192795-7F697D92-80D4-4222-A8F9-032E759EB737 Q45324769-81F27D1A-F739-4E3A-B492-0D79F53F4287 Q51846287-BE3BD6FD-91FC-4DA5-9578-22FCAB9E8F6A

P2860

Triptolide-mediated inhibition of interferon signaling enhances vesicular stomatitis virus-based oncolysis.

http://www.wikidata.org/entity/Q37316872

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Triptolide-mediated inhibition ...... matitis virus-based oncolysis.

@en

Triptolide-mediated inhibition ...... matitis virus-based oncolysis.

@nl

type

label

Triptolide-mediated inhibition ...... matitis virus-based oncolysis.

@en

Triptolide-mediated inhibition ...... matitis virus-based oncolysis.

@nl

prefLabel

Triptolide-mediated inhibition ...... matitis virus-based oncolysis.

@en

Triptolide-mediated inhibition ...... matitis virus-based oncolysis.

@nl

P1433

Q37316872-3AB77F79-0AD3-4423-9315-FA0BB23F2F38

P1476

Q37316872-8CF3A028-B151-486F-9AE9-E7068E55D567

P2093

Q37316872-04687FA8-C7B4-4D78-A3C1-19E795B23755

Q37316872-33A3637D-2A7B-4D6E-BAFE-D8D5AF3006EA

Q37316872-3486FACC-C6F6-496A-8533-7C6E2B8A2707

Q37316872-45F951DC-C4B3-4E78-AB63-E3B0EBDC89A4

Q37316872-4C3A56E7-0775-4F93-BDD5-CA9E74C1CF30

Q37316872-8A737C76-1ADD-47C1-B6C7-7F371764F6D0

Q37316872-AC3A8862-9196-4AF6-BD2F-569368655BC7

Q37316872-FEAFF412-9447-447A-96CF-842917305ADD

P2860

Q37316872-0180AABF-8567-4A04-8010-F62B2A1B5650

Q37316872-02AA0BE0-A180-421F-847D-8DFCA445F908

Q37316872-0496B755-2872-4A51-AB70-8C6534A7088C

Q37316872-07CF7514-D0FC-4326-9EB8-5A47175AC065

Q37316872-094FAC46-5FDE-4546-A9ED-E6F049F2B4FB

Q37316872-0A59D358-386F-4368-9977-82EEA43FF466

Q37316872-14F5B1E1-A227-40A2-BE19-30307F65A16D

Q37316872-16A605FE-3E6C-4990-851D-BF916D985AF5

Q37316872-190A5DEF-630B-44BE-AB8B-91040FC7389F

Q37316872-1A0ADD0E-19E4-4735-B4CF-6140D0FD7CB0

P304

Q37316872-089F28C7-6E14-4E9A-B80C-8F06EEEF2A39

P31

Q37316872-AFAF044B-70BB-4BCC-B193-27369566359A

P356

Q37316872-9F64C95A-E044-43B2-AB0F-DE6F246FFF3E

P433

Q37316872-7B4B7C1A-BCE4-443D-BF4B-E3EA93CB51E5

P478

Q37316872-0F9D5FE6-E3FB-4D07-A4D3-CF64007A799B

P577

Q37316872-12A78FDD-AAAB-4F63-BFCB-1A484AFB0936

P5875

Q37316872-78B2759A-3B2A-42B1-88FF-1FFD6971DDC7

P698

Q37316872-353A0B48-9BC9-4518-981F-73570B952264

P932

Q37316872-91C2397D-7D7A-428F-8315-E03C027D184F

P356

P1433

Molecular Therapy

P1476

Triptolide-mediated inhibition ...... matitis virus-based oncolysis.

@en

P2093

David F Stojdl

http://www.w3.org/2001/XMLSchema#string

Fethia Ben Yebdri

http://www.w3.org/2001/XMLSchema#string

Jian Hui Wu

http://www.w3.org/2001/XMLSchema#string

John Hiscott

http://www.w3.org/2001/XMLSchema#string

Julien Van Grevenynghe

http://www.w3.org/2001/XMLSchema#string

Marie-Line Goulet

http://www.w3.org/2001/XMLSchema#string

Rongtuan Lin

http://www.w3.org/2001/XMLSchema#string

Vera A Tang

http://www.w3.org/2001/XMLSchema#string

P2860

MyD88-dependent and independent pathways of Toll-Like Receptors are engaged in biological activity of Triptolide in ligand-stimulated macrophages

Vesicular stomatitis virus oncolysis is potentiated by impairing mTORC1-dependent type I IFN production.

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus.

Synergistic interaction between oncolytic viruses augments tumor killing.

Triptolide (TPL) inhibits global transcription by inducing proteasome-dependent degradation of RNA polymerase II (Pol II).

Triptolide and its expanding multiple pharmacological functions.

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents.

Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses.

VSV oncolysis in combination with the BCL-2 inhibitor obatoclax overcomes apoptosis resistance in chronic lymphocytic leukemia.

Triptolide, a novel immunosuppressive and anti-inflammatory agent purified from a Chinese herb Tripterygium wilfordii Hook F.

P304

2043-2053

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MT.2013.187

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256201232

http://www.w3.org/2001/XMLSchema#string

P698

23985699

http://www.w3.org/2001/XMLSchema#string

P932

3831042

http://www.w3.org/2001/XMLSchema#string